TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.24), versus ($2.08) reported last year. Revenue for the quarter came in at $400 thousand, versus $700 thousand reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.